Convocatoria Postdoctoral La investigacion es cosa de todos Annual report

Home | News | Publications

Publications

Elena Castro and David Olmos Translational
09.01.2019
CNIO researchers confirm links between aggressive prostate cancer and hereditary breast cancer Aggressive prostate cancer, one of the leading causes of cancer deaths in men, is associated with...
p62 Basic Research
20.12.2018
Researchers from the CNIO and the Hospital 12 de Octubre make sense out of the chaos of melanoma Unlike other skin cancers – and without knowing really why – melanoma is one of the most...
Mielofibrosis Translational
18.12.2018
The CNIO and Hospital 12 de Octubre find a potential new combination therapy against a rare disease of the bone marrow Myelofibrosis is a severe and very rare haematological disease for which treatment has only been...
Lung Cancer Clinical Research Unit H12O-CNIO Innovation
Translational
03.12.2018
An international clinical trial extends the effectiveness of immunotherapy to more lung cancer patients The strategy for triggering the patient’s own immune system to attack cancer, immunotherapy, is...
H12O-CNIO Haematological Malignancies Clinical Research Unit Innovation
Translational
21.11.2018
A new methodology predicts the risk of relapse in patients with acute myeloid leukemia The acute myeloid leukemia (AML) is the most common haematological cancer in adults. With a 5-year...
David Olmos Innovation
Translational
13.11.2018
First blood-based biomarker in response to the treatment of the most aggressive prostate cancer In collaboration with British and Italian researchers
Trombocitopenia-2 Basic Research
Innovation
30.10.2018
CNIO finds the origin of a type of thrombocytopenia caused by an oncogene The Cell Division and Cancer Group of the Spanish National Cancer Research Centre (CNIO) has...
Basic Research
30.08.2018
An international team led by the CNIO reveals that human genome could contain up to 20% fewer genes A new study led by the Spanish National Cancer Research Centre (CNIO) reveals that up to 20% of...
first indicators of prognosis for the most aggressive type of breast cancer Innovation
Translational
29.08.2018
CNIO researchers find the first indicators of prognosis for the most aggressive type of breast cancer The rarest, but also the most aggressive and hard to treat form of breast cancer, is known as triple...

Up